# Imperative Care

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imperative-care

- Industry: Medical Devices & Equipment
- Headquarters: Campbell, US
- Website: www.imperativecare.com
- Total disclosed funding: $419M
- Latest round: Series E (Jul 23, 2024)
- Investors on record: 16

## About

Imperative Care, Inc., based in the US, specializes in developing innovative medical devices aimed at addressing critical health challenges related to ischemic stroke and vascular diseases.Founded in 2015 and headquartered in Campbell, California, Imperative Care, Inc. focuses on creating interventional solutions for ischemic stroke.In March 2026, Imperative Care, Inc. raised USD 100 million in venture debt funding. The founder has a history of establishing ventures in the medical device sector.Imperative Care specializes in innovative interventional solutions for ischemic stroke and other vascular diseases. Their flagship product, the Zoom Stroke System, facilitates effective clot removal for stroke patients. Additionally, the Vascular portfolio includes the Prodigy® and Symphony® Thrombectomy Systems, targeting venous thromboembolism and acute limb ischemia. The company caters to healthcare providers in the US and is expanding into Europe and Asia, enhancing patient care through advanced medical technologies.Imperative Care generates revenue through direct sales of its medical devices to healthcare facilities, primarily utilizing a business-to-business (B2B) model.

The company will use the March 2026 funding to enhance the commercialization of its stroke and vascular thrombectomy portfolios.

## Funding rounds

- Series E, Jul 23, 2024, $73M — Bain Capital, HealthCor Group, Pura Vida Investments, Rock Springs Capital, Ally Bridge Group, Innovatus Capital Partners, D1 Capital Partners, AMED Ventures, Montreux Growth Partners, Catalio Capital Management, INTAI Technology
- Series D, Jul 15, 2021, $260M — Bain Capital, Ascension Ventures, HealthCor Group, Rock Springs Capital, Ally Bridge Group, Delos Capital Partners, Innovatus Capital Partners, D1 Capital Partners, AMED Ventures
- Series C, Feb 26, 2020, $7M — Bain Capital, Ascension Ventures, Rock Springs Capital, Ally Bridge Group, Delos Capital Partners
- Series C, Nov 26, 2019, $79M — Bain Capital, Rock Springs Capital, Ally Bridge Group, Delos Capital Partners, Ascension, Incept, 3H Health Investment

## Investors

- Bain Capital (https://capitalatlas.ai/funds/bain-capital) — Series C, Series D, Series E
- Rock Springs Capital — Series C, Series D, Series E
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series C, Series D, Series E
- Delos Capital Partners (https://capitalatlas.ai/funds/delos-capital-partners) — Series C, Series D
- Ascension (https://capitalatlas.ai/funds/ascension) — Series C
- Incept (https://capitalatlas.ai/funds/incept) — Series C
- 3H Health Investment (https://capitalatlas.ai/funds/3h-health-investment) — Series C
- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series C, Series D
- HealthCor Group (https://capitalatlas.ai/funds/healthcor-group) — Series D, Series E
- Innovatus Capital Partners (https://capitalatlas.ai/funds/innovatus-capital-partners) — Series D, Series E
- D1 Capital Partners (https://capitalatlas.ai/funds/d1-capital-partners) — Series D, Series E
- AMED Ventures (https://capitalatlas.ai/funds/amed-ventures) — Series D, Series E
- Pura Vida Investments (https://capitalatlas.ai/funds/pura-vida-investments) — Series E
- Montreux Growth Partners (https://capitalatlas.ai/funds/montreux-growth-partners) — Series E
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series E
- INTAI Technology — Series E